Research Article

The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas

Volume: 13 Number: 1 March 26, 2022
EN TR

The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas

Abstract

Aim: Clinical manifestations of celiac disease (CD) can be quite different and varying. The number of CDs presenting with atypical symptoms is increasing day by day. Hence, we aimed to determine how many patients with CD were atypical celiac through examining their admission complaints, clinical characteristics, laboratory results, endoscopic findings, and pathological findings. Material and Methods: Eighty-nine patients with CD aged over 18 years who were followed-up in Ankara Kecioren Training and Research Hospital Internal Medicine Clinic between 2007 and 2014 were included in the study. The files of the patients were reviewed retrospectively. Sex, age, hospital admission complaints, clinical characteristics, laboratory results, endoscopy findings, and pathology results of the patients were recorded. Results: The median age of the patients in the study was 36, and 68.5% of them were female. The most common symptoms of the patients were fatigue (49.4%), anorexia (33.7%), and dyspepsia (22.5%), while diarrhea (19.1%), which is among the classical symptoms, was less common. 7.8% of the patients had no complaints at the time of admission, whereas 47.1% of them had only extraintestinal symptoms. At admission, 47% of the patients had anemia, 73.4% had iron deficiency, and 55.4% of them had vitamin B12 deficiency. When hemoglobin, ferritin, and vitamin B12 levels were compared before and after a gluten-free diet, a significant increase was determined. Transaminase elevation was detected in 25.3% of our patients at the time of diagnosis. When pre-treatment and post-treatment values were compared, a significant decrease was determined in those with high transaminase levels. In the pre-treatment serological test results of the patients, Ig A EMA positivity was the most common finding with a rate of 90.2%, followed by IgG EMA with 88.9%. In terms of pre-treatment endoscopy findings, 50.2% of our patients had normal appearance, 25.4% had a mosaic pattern, 12.6% had effacement of the duodenal folds, 12.6% had a nodular appearance, and 9.5% had a scalloping of the duodenal folds. When the pathology results of our patients were examined, 83.4% of them were at the advanced stage and with Marsh Type 3. Conclusion: CD may present with atypical complaints such as extraintestinal findings, as in more than half of the patients in this study. Celiac disease should be taken into consideration, particularly in conditions such as iron deficiency, osteoporosis, and transaminase elevations, which are prevalent in the community. The prevalence of CD in our country is estimated to be around 1-2%; however, it is considered that there are more asymptomatic patients with atypical celiac disease. When diagnosing CD, the most crucial step is to consider the potential presence of CD during pre-diagnoses. Thus, CD should be included in the differential diagnosis, specifically in patients presenting with atypical symptoms.

Keywords

References

  1. 1. Rubin CE, Branborg LL, Phelps PC, et al. Apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue. Gastroenterology 1960; 38: 28-49.
  2. 2. Arranz E, Ferguson A. Intestinal antibody pattern of celiac disease: occurrence in patients with normal jejunal biopsy histology. Gastroenterology. 1993; 104: 1263-72.
  3. 3. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8.
  4. 4. Sanders DS, Carter MJ, Hurlstone DP, et al. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet. 2001; 358: 1504-8.
  5. 5. Corazza GR, Di Sario A, Cecchetti L, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995; 109: 122-8.
  6. 6. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960–5.
  7. 7. Fasano A, Berti I, Gerrarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003; 163: 286–92.
  8. 8. Ertekin V, Selimoglu MA, Kardas F, et al. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol 2005; 39: 689-91.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Publication Date

March 26, 2022

Submission Date

December 21, 2021

Acceptance Date

December 24, 2021

Published in Issue

Year 2022 Volume: 13 Number: 1

APA
Karakaya, S., Karadağ, İ., Mete, A., Bulur, O., Uzman, M., & Beyan, E. (2022). The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas. Turkish Journal of Clinics and Laboratory, 13(1), 64-70. https://doi.org/10.18663/tjcl.1039075
AMA
1.Karakaya S, Karadağ İ, Mete A, Bulur O, Uzman M, Beyan E. The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas. TJCL. 2022;13(1):64-70. doi:10.18663/tjcl.1039075
Chicago
Karakaya, Serdar, İbrahim Karadağ, Aslıhan Mete, Oktay Bulur, Metin Uzman, and Esin Beyan. 2022. “The Invisible Part of ‘ICEBERG’:Extraintestinal Findings and Celiac Diseas”. Turkish Journal of Clinics and Laboratory 13 (1): 64-70. https://doi.org/10.18663/tjcl.1039075.
EndNote
Karakaya S, Karadağ İ, Mete A, Bulur O, Uzman M, Beyan E (March 1, 2022) The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas. Turkish Journal of Clinics and Laboratory 13 1 64–70.
IEEE
[1]S. Karakaya, İ. Karadağ, A. Mete, O. Bulur, M. Uzman, and E. Beyan, “The invisible part of ‘ICEBERG’:Extraintestinal findings and celiac diseas”, TJCL, vol. 13, no. 1, pp. 64–70, Mar. 2022, doi: 10.18663/tjcl.1039075.
ISNAD
Karakaya, Serdar - Karadağ, İbrahim - Mete, Aslıhan - Bulur, Oktay - Uzman, Metin - Beyan, Esin. “The Invisible Part of ‘ICEBERG’:Extraintestinal Findings and Celiac Diseas”. Turkish Journal of Clinics and Laboratory 13/1 (March 1, 2022): 64-70. https://doi.org/10.18663/tjcl.1039075.
JAMA
1.Karakaya S, Karadağ İ, Mete A, Bulur O, Uzman M, Beyan E. The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas. TJCL. 2022;13:64–70.
MLA
Karakaya, Serdar, et al. “The Invisible Part of ‘ICEBERG’:Extraintestinal Findings and Celiac Diseas”. Turkish Journal of Clinics and Laboratory, vol. 13, no. 1, Mar. 2022, pp. 64-70, doi:10.18663/tjcl.1039075.
Vancouver
1.Serdar Karakaya, İbrahim Karadağ, Aslıhan Mete, Oktay Bulur, Metin Uzman, Esin Beyan. The invisible part of “ICEBERG”:Extraintestinal findings and celiac diseas. TJCL. 2022 Mar. 1;13(1):64-70. doi:10.18663/tjcl.1039075